These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4274674)

  • 21. Lack of relationship between brain (Na + + K +)-activated adenosine triphosphatase and the development of tolerance to ethanol in rats.
    Akera T; Rech RH; Marquis WJ; Tobin T; Brody TM
    J Pharmacol Exp Ther; 1973 Jun; 185(3):594-601. PubMed ID: 4268232
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on characterization of the sodium-potassium transport adenosine-triphosphatase. 3. Synthesis of strophanthidin 3-[1-14C] bromoacetate for affinity labeling of the cardiotonic steroid site.
    Ruoho AE; Meitner PA; Hokin LE
    Anal Biochem; 1969 Apr; 28(1):119-29. PubMed ID: 4238447
    [No Abstract]   [Full Text] [Related]  

  • 23. Membrane adenosine triphosphatase. The effect of potassium on the formation and dissociation of the ouabain-enzyme complex.
    Akera T; Brody TM
    J Pharmacol Exp Ther; 1971 Mar; 176(3):545-57. PubMed ID: 4255765
    [No Abstract]   [Full Text] [Related]  

  • 24. Lithium and rubidium interactions with sodium- and potassium-dependent adenosine triphosphatase: a molecular basis for the pharmacological actions of these ions.
    Tobin T; Akera T; Han CS; Brody TM
    Mol Pharmacol; 1974 May; 10(3):501-8. PubMed ID: 4277565
    [No Abstract]   [Full Text] [Related]  

  • 25. Further studies on the correlation between the inotropic action of ouabain and its interaction with the Na+,K+-adenosine triphosphatase: isolated perfused rabbit and cat hearts.
    Schwartz A; Allen JC; Van Winkle WB; Munson R
    J Pharmacol Exp Ther; 1974 Oct; 191(1):119-27. PubMed ID: 4278708
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhition of sodium and potassium independent adenosine triphosphatase by uranyl ion.
    Miyama A; Kogami J; Kashiba S
    Biken J; 1969 Jun; 12(2):141-3. PubMed ID: 4242566
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics.
    Palatini P
    Mol Pharmacol; 1977 Mar; 13(2):216-23. PubMed ID: 192990
    [No Abstract]   [Full Text] [Related]  

  • 28. An allosteric explanation for ouabain-induced time-dependent inhibition of sodium, potassium-adenosine triphosphatase.
    Allen JC; Lindenmayer GE; Schwartz A
    Arch Biochem Biophys; 1970 Nov; 141(1):322-8. PubMed ID: 4249246
    [No Abstract]   [Full Text] [Related]  

  • 29. Dissociation of contractile effect and binding and inhibition of Na+-K+-adenosine triphosphatase by cardiac glycosides in rabbit myometrium.
    Murthy RV; Kidwai AM; Daniel EE
    J Pharmacol Exp Ther; 1974 Mar; 188(3):575-81. PubMed ID: 4273912
    [No Abstract]   [Full Text] [Related]  

  • 30. Reversible inhibition of (Na+ + K+)-ATPase with a cardiac glycoside.
    Ross CR; Pessah NI
    Eur J Pharmacol; 1975 Aug; 33(1):223-6. PubMed ID: 126168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mechanism of the Ca++ ion inhibition of sodium-potassium ATPase.
    Tobin T; Akera T; Baskin SI; Brody TM
    Recent Adv Stud Cardiac Struct Metab; 1974; 4():139-47. PubMed ID: 4283207
    [No Abstract]   [Full Text] [Related]  

  • 32. Dissociation of electrophysiological and inotropic actions of strophanthidin-3-bromoacetate: possible role of adenosine triphosphatase in the maintenance of the myocardial transmembrane Na + and K + gradients.
    ten Eick RE; Bassett AL; Okita GT
    J Pharmacol Exp Ther; 1973 Apr; 185(1):12-23. PubMed ID: 4266378
    [No Abstract]   [Full Text] [Related]  

  • 33. Structure-activity relationships of cardiotonic steroids for the inhibition of sodium- and potassium-dependent adenosine triphosphatase. IV. Dissociation rate constants for complexes of the enzyme with cardiac oligodigitoxides.
    Yoda S; Sarrif AM; Yoda A
    Mol Pharmacol; 1975 Sep; 11(5):647-52. PubMed ID: 126365
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibiotics as tools for metabolic studies. XVIII. Inhibition of sodium- and potassium-dependent adenosine triphosphatase.
    Susa JB; Lardy HA
    Mol Pharmacol; 1975 Mar; 11(2):166-73. PubMed ID: 123632
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the characterization of the sodium-potassium transport adenosine triphosphatase. 8. Effects of ligands on fluorescence due to interaction of the enzyme with a fluorescent derivative of hellebrigenin.
    Yoda A; Hokin LE
    Mol Pharmacol; 1972 Jan; 8(1):30-40. PubMed ID: 4258647
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence for two forms of fluoride-treated sodium- and potassium-dependent adenosine triphosphatase.
    Penzotti SC; Titus E
    Mol Pharmacol; 1972 Mar; 8(2):149-58. PubMed ID: 4260221
    [No Abstract]   [Full Text] [Related]  

  • 37. Tetradifon (tedion R ): a specific inhibitor of Mg 2+ dependent mitochondrial adenosine triphosphatase activity.
    Desaiah D; Cutkomp LK; Koch RB; Yap HH
    Life Sci II; 1972 Apr; 11(7):389-95. PubMed ID: 4266328
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac sodium, potassium-adenosine triphosphatase as a possible site of adriamycin-induced cardiotoxicity.
    Solomonson LP; Halabrin PR
    Cancer Res; 1981 Feb; 41(2):570-2. PubMed ID: 6256069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Na+-K+-ATPase and 86Rb-uptake by canrenone.
    Belz GG; Kleeberg UR
    Horm Metab Res; 1973 Jul; 5(4):312. PubMed ID: 4269867
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiac glycoside sensitivity of (Na + +K + )-activated ATPase in new-born rats.
    Akera T; Hook JB; Tobin T; Brody TM
    Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):699-706. PubMed ID: 4264311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.